Antimicrobial Agents and Chemotherapy · 2002 · 187 citations · 12 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacologyMedical MicrobiologyMycologyAntifungal AgentsAntifungal PharmacologyAntifungal ResistanceAntifungal TherapyFungal InfectionsFungal PathogenesisAnimal Disease ModelsAntifungal Drug InteractionsAntifungal Susceptibility TestingAspergillosis TherapyBroth MicrodilutionFractional Inhibitory Concentration IndexInvasive Aspergillosis TreatmentResistance In Clinical Isolates
The interaction between caspofungin acetate and voriconazole was studied in vitro by using 48 clinical Aspergillus spp. isolates obtained from patients with invasive aspergillosis. MICs were determined by the NCCLS broth microdilution method. Synergy, defined as a fractional inhibitory concentration (FIC) index of <1, was detected in 87.5% of the interactions; an additive effect, defined as an FIC index of 1.0, was observed in 4.2% of the interactions; and a subadditive effect, defined as an FIC index of 1.0 to 2.0, was found in 8.3% of the interactions. No antagonism was observed. Animal models are required to validate the in vivo significance of these in vitro data presented for the combination of caspofungin and voriconazole.
12
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Thomas F. Patterson, William R. Kirkpatrick, Mary H. White et al. · Medicine · 2000 · 790 citations
Ana Espinel‐Ingroff · Journal of Clinical Microbiology · 1998 · 577 citations · Full text
Life Sciences, Biology, Microbiology +11